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Abstract
Background: Practice guidelines have been developed in response to the observation that
variations exist in clinical medicine that are not related to variations in the clinical presentation and
severity of the disease. Despite their widespread use, however, practice guideline evaluation lacks
a rigorous scientific methodology to support its development and application.
Discussion:  Firstly, we review the major epidemiological foundations of practice guideline
development. Secondly, we propose a chronic disease epidemiological model in which practice
patterns are viewed as the exposure and outcomes of interest such as quality or cost are viewed
as the disease. Sources of selection, information, confounding and temporal trend bias are identified
and discussed.
Summary: The proposed methodological framework for outcomes research to evaluate practice
guidelines reflects the selection, information and confounding biases inherent in its observational
nature which must be accounted for in both the design and the analysis phases of any outcomes
research study.
Background
The development of practice guidelines
In clinical medicine, variations exist that do not appear to
be related to variations in the clinical presentation and se-
verity of disease [1–3]. In response, practice guidelines
have been developed in an attempt to reduce the wide
practice variations and, through this process, to increase
the appropriateness and quality of medical care and to re-
duce health care costs [4–8].
Despite the publication and dissemination of practice
guidelines [9], there has been relatively little evaluation of
the application and impact of clinical practice guidelines
[9–14]. Some of the difficulty in the evaluation of these
guidelines relates to the methods that were used to devel-
op them [9]. Guidelines have often have been developed
before adequate data have been available to assess the re-
lationship between clinical practice patterns and desired
clinical outcomes. Nevertheless, there have been some re-
views of practice guideline evaluation [15,16].
While epidemiological designs are commonly used to
evaluate the effectiveness of health care interventions,
never has this been discussed in the context of outcomes
research. We propose the use of a methodological frame-
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work for outcomes research to evaluate practice guide-
lines.
Methodological issues with the measurement of practice 
variations
In the debate about reasons to promote the development
of practice guidelines, few have questioned whether the
variations are real, or alternatively, whether they are sim-
ply a function of methodological flaws in the measure-
ment of medical practices themselves, the result of
variations in practice patterns across groups of patients
with a similar diagnosis, or both. Furthermore, few stud-
ies have addressed whether practice variations, in fact,
lead to outcome variations. Finally, little attention has
been paid to the identification and measurement of initial
conditions, that is, the potentially confounding factors
and effect modifiers of the practice patterns outcomes re-
lationship.
Measurement of practice pattern variation
The measurement of medical practice patterns is suscepti-
ble to error. Measurement error may affect the validity of
medical practice measurement in three major ways. First,
it may lead to selection bias, in that subjects are selected
to belong to a certain group based on an erroneous diag-
nosis. Secondly, it may lead to misclassification of expo-
sure (information bias), in that patients treated with a
specific practice pattern are classified in the wrong diag-
nostic group. Thirdly, it may lead to misclassification of
outcomes, in that patients with a given outcome are clas-
sified in the wrong diagnostic group.
Potential problems with the measurement of practice var-
iations relate to the mechanisms that underlie the choice
of groups that are compared in studies of practice varia-
tions. These mechanisms must be defined clearly to min-
imize selection bias. In many studies of practice
variations, populations are arbitrarily divided according
to hospitals, regions, counties, or countries. Little infor-
mation is available about the factors that lead these
groups to go to a particular hospital, live in a particular re-
gion, go to a particular doctor, etc. The population base
from which each comparison group is derived should, in
principle, be quite similar for all groups. Basically, if the
groups are drawn from a similar population, unmeasura-
ble and potentially confounding variables are more likely
to be equally distributed between groups.
In addition, the measurement of practice variations can-
not be valid without information on relevant "initial con-
ditions". Initial conditions are all confounding factors
and effect modifiers, other than the treatment/practice
patterns, that may cause or influence the clinical out-
comes of interest. These factors may explain practice vari-
ations among groups that do not share similar initial
conditions. To evaluate practice patterns-outcomes associ-
ations, potential confounders must be identified and con-
trolled for in the analysis.
Aside from clinical presentation and severity of illness; the
initial conditions to be identified and characterized as
completely as possible include physician, patient, and
practice environment factors (Table 1). Measurement of
such factors is essential to minimize the chance of a sys-
tematic error following confounding biases and effect
modification (Figure 1).
Identification and measurement of outcomes of interest
Limitations to the development and evaluation of practice
guidelines also include the absence of a clear concept of
the targeted outcomes and the paucity of outcomes data
to support these guidelines [17]. There appears to be only
a weak relationship between the purpose of guidelines
and many of the outcomes usually measured in clinical re-
search, that is, the source of evidence for guideline devel-
opment (evidence-based). The initial goals of establishing
practice guidelines – to reduce costs and enhance the
quality and appropriateness of treatment – are, in fact,
rarely the basis for guideline development, since little data
is available for these outcomes. To some degree, the devel-
opment of guidelines has been driven by the availability
of data on clinical outcomes, such as morbidity and mor-
tality, rather than those outcomes related to the primary
goals of the guidelines.
Table 1: Initial conditions to be taken into account when making inferences about practice patterns-outcomes associations
Patient factors Physician factors Environmental factors
Demographics Severity of illness Physicians' beliefs and interpretation of medical 
evidence
Medical insurance status (fee-for-service vs. managed care)
Heterogeneity of disease expression Medical uncertainty Availability of needed procedure
Patient preference Specialist vs. generalist Physicians' skills Proximity of medical centers with appropriate expertise
Patient attitude towards disease Inappropriate use Nature of groupBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/7
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The evaluation of practice guidelines
Throughout the development of practice guidelines, the
major deficiency has been the lack of an evaluative meth-
od [18–27]. Thus, we suggest a methodological frame-
work for outcomes research to be applied to evaluate
practice guidelines. Outcomes research evaluates practice
patterns as they occur in actual clinical settings. This type
of research can describe practice patterns, evaluate their
divergence from practice guidelines and determine the ef-
fect of practice variations on outcomes. Outcomes re-
search is necessarily observational in nature and, although
observational studies have been used to evaluate health
care interventions, the proposed methodological frame-
work has yet to be applied to outcomes research.
Why should outcomes research be used to evaluate and
validate practice guidelines? The primary goal of practice
guidelines is the consistent adherence by physicians to
practice patterns that achieve the "best" outcomes at the
lowest cost. Outcomes research evaluates practice patterns
as they occur in actual clinical settings, and is thus the log-
ical method to evaluate practice guidelines. In fact, out-
comes research and practice guidelines are connected
through concepts that relate to efficacy and effectiveness
research (Figure 2). Efficacy studies, which normally com-
plement practice guideline development, are those per-
formed in highly selected groups of patients to investigate
if a particular intervention works under controlled condi-
tions set by the study investigators. In contrast, outcomes
research evaluates practice as it occurs in actual clinical
settings [28]. Research in these settings is called effective-
ness research because the investigators have limited con-
trol over the conditions that qualify the practice settings.
The difference between efficacy and effectiveness research
can be summarized as follows: does it work at all (effica-
cy) or does it work in the real world (effectiveness)? Thus,
there exists a dynamic process in which evidence from
both effectiveness and efficacy studies feeds into the de-
velopment and evaluation of practice guidelines, as de-
picted in Figure 2.
Most practice guidelines are derived from efficacy studies
rather than effectiveness studies. Therefore, it is not sur-
prising that practice guidelines are not fully applicable in
actual clinical practice. We suggest that effectiveness stud-
ies be used not only as a method to evaluate practice
guidelines but also as a basis for their development. These
could include both observational studies and effective-
ness trials. Outcomes research better reflects practice in
the real world and may make guidelines more likely to be
applied. However, to date, little attention has been paid to
the epidemiological underpinnings of the methods used
to conduct outcomes research.
Discussion
We will first propose a methodological framework for
outcomes research. Then, we will show how it can be used
to evaluate practice guidelines. Finally, we will address the
limitations of the proposed methodological framework.
Generic epidemiological issues in outcomes research
In the proposed methodological framework, the generic
issues related to outcomes research will be discussed in se-
quential order. In outcomes research, the first step is to
identify the study population and the groups (hospitals,
providers, regions, etc.) that will be compared. The next
step is the measurement of practice patterns and out-
comes. After groups are compared on the basis of the
treatment they receive and outcomes of interest, associa-
tions are sought between practice patterns and the various
measures of outcome. This step of the methodological
framework raises issues of confounding bias because not
all factors that can confound these associations are meas-
ured and controlled or even known. The presence or ab-
sence of confounding bias can be affected by the other
sources of bias namely selection and information biases.
Lastly, we discuss the issue of temporal trends. In the eval-
uation of practice guidelines, the measurement of practice
patterns may not be contemporaneous with the publica-
tion of practice guidelines. This may explain and even lead
to the frequently observed discrepancy between the actual
practice and what the guidelines state that it should be. Fi-
nally, two particularities of outcomes research 1) the pres-
ence of ecological exposures in individual level studies
and 2) the common use of large administrative databases
are discussed.
Figure 1
Practice Guidelines 
Practice Variations  “Optimal Practice”
Classified Diagnoses 
Initial Conditions (Individual and Group Level) 
Figure 2
Relationship between outcomes research and practice guide-
lines
Efficacy Studies 
= 
Practice Guidelines Development
Effectiveness Studies  Practice Guidelines Evaluation 
= 
Outcomes Research  Clinical Research BMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/7
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Specification of the model
Definition of the elements of the proposed epidemiological model for 
outcomes research
In the proposed model for outcomes research designed to
evaluate practice guidelines, the outcome of interest can
be a disease (Table 2). For example, if the practice patterns
that are being studied pertain to coronary revasculariza-
tion, complications such as mortality and reinfarction af-
ter acute myocardial infarction may constitute the
outcome of interest. Finally, the consequences of different
practice patterns on medical resources (cost, quality and
appropriateness) may be another possible outcome of in-
terest.
In the studies of outcome research, practice patterns,
(which constitute the exposure in the proposed model),
range from the use of medication, diagnostic tests and
therapeutic procedures to the length of hospital stay,
transfer to other facilities and/or scheduled physicians vis-
its. The primary goal of outcomes research is the evalua-
tion of the effects of the selected practice patterns on the
outcomes of interest. Consequently, any inference made
about this association must be evaluated as a function of
the potential selection, information (measurement error)
and confounding biases. A limitation of outcomes re-
search as it is most often performed is the lack of attention
given to the measurement of each of the elements of the
epidemiological model shown in Table 3. The basis of the
proposed methodological framework will be the identifi-
cation of generic sources of potential bias that relate to
each element of the proposed model.
Selection bias
Since outcomes research is observational in nature, the
choice of the study population and of the compared
groups is highly susceptible to selection bias. As applied to
outcomes research, selection bias is defined as a distortion
in the estimate of the practice patterns outcomes associa-
tion due to the way that subjects are selected for inclusion
in the study population and in the different groups to be
compared [29]. A major consequence of selection bias is
the potential confounding of inferences made about prac-
tice patterns-outcomes associations. This occurs when
some characteristics of the subjects related to practice pat-
terns or clinical outcomes influence the selection or exclu-
sion of individual subjects, groups of subjects or practice
environments.
The selection process should be such that patients includ-
ed in the study population come from the same target
population [30]. Furthermore, patients or study members
should have a similar probability of being selected and in-
cluded in the actual population. Inclusion and exclusion
criteria must be clearly defined in order to characterize the
actual population as precisely as possible. Judging the in-
ternal validity of a study is more feasible when there is a
detailed account of how the individuals were selected to
become members of the actual population. Finally, the
study population, also needs to be carefully characterized
so that the inferences derived from the analysis of the
study population can be evaluated for both internal valid-
ity (based on the data analyzed in the study) and external
validity (the extent to which results obtained from the
data analyzed in a particular study can be generalized to
populations outside of the study). Any systematic differ-
ences between those actually studied and the source (tar-
get) population could result in biased estimates of the
impact of a practice pattern on a clinical outcome.
In many studies of outcomes research, groups exposed to
different practice patterns are compared. The identifica-
tion of such groups of patients is sought to assess the im-
pact of different practice patterns on various outcomes in
actual clinical settings and, as previously mentioned, can
be used to assess practice guidelines. Because of such
study design, it becomes unclear as to what the target pop-
ulation precisely is. Is it the group (the set of patients in a
given environment) or is it the individuals receiving the
various practice patterns within each group? For example,
in a study of regional variations in the treatment of acute
Table 2: Epidemiological model for outcomes research to evaluate practice guidelines
Outcome = Exposure + Confounders + Error
• Clinical outcomes 
(for example, disease 
development, compli-
cations)
• Practice patterns • Extraneous factors that can influence practice 
patterns and outcomes, that is, initial conditions
• Misclassification of diagnosis, practice pat-
terns and outcomes
• Quality • Error in measurement of practice patterns 
and outcomes
• Cost
• Appropriateness • Unmeasured factorsBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/7
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myocardial infarction in the U.S., the treatment of pa-
tients (practice patterns) was compared across different re-
gions of the U.S. In this study, one wishes to generalize the
findings about practice patterns-outcomes associations to
all individuals with acute myocardial infarction (individ-
ual level). One also wishes to generalize the effect of the
exposure, which is in this case practice patterns, to those
prevalent in a given region (ecological level).
The presence of these two levels, the individual and the ec-
ological levels, introduces an added level of complexity in
terms of the assessment of the effect of the exposure on
outcome. When comparing practice patterns across re-
gions using individual data, there is a certain degree of
correlation brought about by the clustering of practice
patterns that needs to be taken into account. Such a corre-
lation is very difficult to quantify. In contrast, when as-
sessing the effect of the exposure at the individual level,
there are ecological factors (initial conditions particular to
a given region) that need to be taken into account. The
data originating from studies with mixed design, which
are often the design of outcomes research studies, need to
be analyzed with special attention to the degree of corre-
lation between the individual covariates and to the pres-
ence of ecological exposure variables.
Another potential source of selection bias is the choice of
the groups to be compared, which depends on the criteria
used to divide the groups. Individuals included in the
groups to be compared should have the same probability
of being included in these groups. Not infrequently in
outcomes research, geographic criteria (such as country,
regions, hospitals) are used because such criteria allow the
identification of clinically comparable groups that receive
very different treatments, whose resulting outcomes can
then be assessed. However, such a process must be scruti-
nized for the possibility of selection bias other than the
treatments that are being evaluated. Such selection bias
would make groups not comparable as to clinical and oth-
er factors that could affect outcomes.
The presence of a biased selection process could lead to
confounding bias when practice patterns-outcomes asso-
ciations are assessed. Such a situation may occur when the
study groups are not comparable with regard to some
characteristics of the subjects related to practice patterns
or clinical outcomes that influenced the selection or exclu-
sion of individual subjects, groups of subjects or practice
environments. For example, in the same study of regional
variations in the treatment of acute myocardial infarction,
census regions of the U.S. were arbitrarily chosen as a ba-
sis for comparison. In this example, patients with similar
risk of developing the outcome of interest, which is de-
fined here as a complication after acute myocardial infarc-
tion, may not have had the same probability of being
included in the different groups to be compared. Con-
founders may then bias the practice patterns/outcomes as-
sociation if the selection of different risk groups is related
to practice patterns.
Selection bias can also affect the assessment of outcomes.
Potential sources of this bias include loss to follow-up or
missing data. Follow-up data is difficult to obtain in out-
comes research studies, which often rely on administra-
tive databases for data acquisition. Linkage, either of
different databases or of the same database over time, is
often performed [31]. A failure to link the databases for a
number of individuals presents a problem equivalent to
having data missing for these individuals.
Information bias
The second step in outcomes research studies is the meas-
urement of practice patterns and of the outcomes of inter-
est. Here, issues of information bias must be considered.
Information bias can be defined as a distortion of the po-
tential practice patterns outcomes association due to mis-
classification of subjects with regard to practice patterns,
outcome measures or both, or due to measurement error
[29].
There are two major ways in which practice patterns can
be misclassified. They relate to the sensitivity and specifi-
city of the tests that are used for the diagnosis for which
practice patterns are being evaluated and for the classifica-
tion of the outcomes of interest. The measurement of the
different practice patterns and their related outcomes
largely depend on the identification of a group of patients
who have a given diagnosis and require a given treatment.
The characteristics that make a diagnosis more amenable
to outcomes research are the following: 1) a precise diag-
nostic definition, 2) a diagnostic test with high sensitivity
and specificity, 3) reproducibility among different indi-
viduals and locations, 4) easily coded, 5) related to a pro-
cedure, and 6) common and costly, so that it is likely to
be collected in large, administrative databases frequently
used in outcomes research. Because of such requirements,
only a limited number of clinical conditions are amenable
to outcomes research. Acute myocardial infarction is an
example of a diagnosis that can be made with a high level
of certainty because it has a precise diagnostic definition
and well-defined diagnostic criteria, which, when taken
together, have high sensitivity and specificity for the cor-
rect classification of patients. Therefore, it is easy to iden-
tify a study population that, in fact, has this disease and to
describe their treatment. Thus, in order to minimize the
misclassification of relevant practice patterns, the meth-
ods used to classify the disease and the outcomes that re-
late to the practice patterns under investigation must have
high sensitivity and specificity [29,31,32].BMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/7
Page 6 of 11
(page number not for citation purposes)
Given the principles underlying the measurement of prac-
tice patterns and outcomes, how are the measurements
generally made in outcomes research studies? The meas-
urement of the exposure (practice patterns) in outcomes
research is valid only if it corresponds to the "true" prac-
tice as performed in the clinical setting. Again, practice can
only be "true" if the diagnosis is correct. The identification
of both patients with the disease of interest and their treat-
ment requires a source of information that has the fea-
tures of a diagnostic test.
In outcomes research, administrative databases are often
used as an information source to identify a study popula-
tion and to obtain data on exposure. The database coding
of diagnoses and procedures can be used as a "diagnostic
test" to identify the clinical condition for which practice
patterns will be described and to classify the practice pat-
terns themselves and the outcomes of interest. Such a "di-
agnostic test" will have higher sensitivity and specificity
values for some diagnoses than for others.
For example, administrative database coding will have
higher sensitivity and specificity for procedure-related di-
agnoses (such as hip fracture) because the diagnostic code
is related to a major operation and is likely to be recorded
for administrative purposes. In contrast, a diagnostic crite-
rion for osteoarthritis can be quite vague and administra-
tive coding is likely to have very low sensitivity and
specificity for this diagnosis.
The use of databases as a diagnostic test must be validated
in all outcomes research studies, especially those using ad-
ministrative databases. Methods to validate these databas-
es include chart reviews, a priori coding systems or both.
These validation methods ensure that coding is as accurate
and reproducible as possible, thus allowing the database
to be used as a diagnostic test to identify the study popu-
lation and the practice patterns and the outcomes in out-
comes research. However, these validation methods are
rarely used.
Finally, appropriate measures of outcomes that will serve
to evaluate practice guidelines must be identified. This
presents a problem because most practice guidelines aim
to reduce practice variations, which will, in turn, lead to
improved appropriateness and quality of care. However,
how appropriateness and quality of care are measured is
controversial and will not be discussed here [33–97]. Nev-
ertheless, defining the outcomes that will be used to eval-
uate practice guidelines is a crucial step in this process.
Quality of life and functional status measures constitute
another group of outcome measures that should be in-
cluded for the evaluation of practice guidelines. These di-
mensions of outcomes have received more attention from
health providers, while consumers have become more
concerned about outcomes of care. However, these out-
comes also are difficult to measure, because they rely
heavily on patient interviews and questionnaires. They are
likely to vary with patient expectations, culture, and cli-
mate and are thus potentially to be measured with error
and be misclassified. A few reliable, valid instruments
have been developed to assess health-related quality of
life [91,92], but such instruments are not easily used to
collect this information from large databases. There is a
need to develop instruments to measure these types of
outcomes, whether they are conversion factors for existing
databases (such using length of stay as a proxy for cost) or
new measures that could easily be integrated in adminis-
trative databases. Such measures could include estimates
of functional class or severity of illness.
At present, many outcomes research studies measure mor-
tality and disease-specific morbidity. The validity of the
measurement of these outcomes is limited by the type of
database that is used. For example, using death registries
to obtain causes for death is a notoriously invalid source
for this type of information. There are many examples of
poor correlation between cause of death as established by
death registries versus disease registries. Death certificates
in New York City during 1992 were assessed to determine
the accuracy and frequency of reporting tuberculosis as a
cause of death. Of 310 persons who died with active tu-
berculosis in 1992 (based on a disease-specific registry),
only 34% had tuberculosis listed on their death certificate.
Thus, in this example, as in many others like it, using
death certificates led to an inaccurate measure of disease
burden [98].
Confounding bias
In outcomes research terms, confounding bias is present
when the effect of the practice variations on the outcomes
of interest is distorted because of the effects of extraneous
variables (variables that are causally associated with the
practice variations and the outcomes of interest) [29]. This
issue is crucial in outcomes research because, while out-
comes research shares the purpose of a clinical trial (to
evaluate different treatments), it primarily uses observa-
tional methods – investigators conducting outcomes re-
search have limited control over potentially confounding
factors (the initial conditions of individual groups of pa-
tients). Because outcomes research builds on existing
practice variations and analyses the natural ongoing ex-
periment, there is ample opportunity for confounding
bias to invalidate any inference made about practice pat-
terns outcome associations [99]. For example, variations
in practice patterns could reflect variation not only in the
use of a given procedure but also in the severity of disease.
Assignment of patients to certain procedures on the basis
of the severity of illness makes sense clinically, but in out-BMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/7
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comes research, it is a common and important source of
confounding if the procedure is either efficacious or par-
ticularly harmful in high-risk patients. Many indices have
been developed to measure the severity of illness when us-
ing existing databases to correct for such confounding, but
one can never be sure that this type of confounding has
been entirely controlled [100,101]. This presents an in-
trinsic limitation of outcomes research.
Avoidance of confounding bias is limited by the source of
data used to describe practice patterns, particularly when
observational data, such as the large Medicare administra-
tive databases, are used to compare outcomes among pa-
tients who receive different treatments. The potential for
confounding bias arises because many factors other than
the treatment under evaluation may affect patient out-
comes. These factors include comorbid diseases, severity
of illness, and patient, physician and environmental fac-
tors. Such factors are likely to influence treatment deci-
sions but are difficult to capture fully in recorded data.
Researchers cannot adjust for imbalances in prognostic
factors that are unmeasured or poorly categorized and ad-
ministrative data, in particular, may lack the precise and
accurate coverage of clinical details needed to permit full
and fair adjustments. Further data collection might solve
this issue, but it is not always possible to collect additional
information. Standard statistical modeling can attempt to
adjust for the known differences between the groups, but
this might not be sufficient for unmeasured differences.
Several alternative methods have been suggested. One
method is subgroup analysis [102] to adjust for unmeas-
ured differences between groups of individuals who differ
on known risk factors. Another method consists of the use
of instrumental variables [103,104]. Instrumental varia-
bles are observable factors that influence treatments but
do not directly affect patient outcomes. This approach
uses the so-called instrumental variables to mimic a rand-
omization of patients to different likelihoods of receiving
alternative treatments. McClellan et al.[103] applied this
methodology to assess whether more aggressive use of in-
vasive cardiac procedures improved outcomes in the eld-
erly. In this study, the instrumental variable was the
distance of the patient's residence from the nearest hospi-
tal with on-site angiography. The authors noted lower
mortality among elderly individuals who received more
aggressive treatment than among those treated more con-
servatively.
Temporal trend bias
We propose a bias called a "temporal trend bias" that is
particular to the use of outcomes research to evaluate
practice guidelines. This bias results from the inability to
control for secular trends. It reflects the fact that by the
time practice guidelines are published and disseminated,
new treatments and technology are being incorporated
into clinical practice. Thus, it is difficult to identify a pure
application of a practice guideline whose application is
not undermined by recent advances in medicine and tech-
nology. For example, we evaluated the effect of a specific
set of guidelines on return to work after acute myocardial
infarction. The use of these guidelines had been successful
in a university setting; this study assessed their use in a
community setting. During the 5 years that elapsed be-
tween these two studies, practices changed. The use of
guidelines was less successful in the community not only
because they did not influence practice but also because
usual care had grown closer to the proposed guidelines
[105].
Ecological exposure in individual level studies
A frequently encountered particularity of outcomes re-
search study design is the presence of both ecological ex-
posure and individual level covariates in the same
analysis. Because the unit of analysis is a group, but infer-
ences are made about the impact of a given practice pat-
tern on individual outcomes, many outcomes research
analyses have elements of both individual and ecological
analyses [106]. In our study of regional variations in the
treatment of acute myocardial infarction, measures de-
scribing practice patterns at the regional level, ecological
exposure, (proportion of patients receiving angiography,
angioplasty, and coronary artery bypass surgery) were
linked to the outcome measures of mortality adjusting for
individual level variables that measured severity of dis-
ease. Then, inferences were made about the use of these
procedures at the patient level. Although the unit of anal-
ysis is the region, which would demand an ecological
analysis, there are individual level covariates, which are
likely to be correlated within each region, that need to be
taken into account.
When group measures are used that contain individual-
level variability with some degree of correlatedness (with-
in region) and aggregate-level variability (between re-
gions), specific analytic tools must be used. It has been
suggested that hierarchical logistic regression modeling be
used to examine the interplay between sources of varia-
tion in the use of health-care services, that is, between ec-
ological-level and individual-level sources. This type of
modeling is designed to separate true variability across ar-
eas from observed variability. An application of this meth-
od is the work by Gatsonis et al.[107] who found that
practice variations across regions of the U.S. in the use of
angiography after acute myocardial infarction were largely
explained by differences in patient characteristics and ge-
ographic region. However, states that had more on-site
availability of angiography still tended to have higher an-
giography rates after accounting for between-region and
within-region variability. After analysis for sources of var-BMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/7
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iability, more reliable inferences about the associations
between practice patterns and outcomes can be made.
Sources of data
The application of the proposed methodological frame-
work for outcomes research largely depends on the sourc-
es of data that are used to evaluate the effect of the practice
variations on outcomes [56]. Most commonly, the study
design is a retrospective cohort analysis and the dataset
that is used has been obtained either for administrative
purposes (discharge databases) or for a randomized clini-
cal trial that addressed a different question [108]. Less of-
ten, a prospective cohort study is designed to evaluate a
particular set of practice guidelines [109]. Although a pro-
spective design provides more control in data collection
than a retrospective analysis, both designs are subject to
selection, information and confounding biases.
The ideal database to use for the evaluation of practice
guidelines is one that allows the precise measurement of
the practice patterns (exposure) and outcomes (disease)
as well as the measurement of potential confounders (se-
verity of illness, precision of diagnosis, socioeconomic
characteristics). Unfortunately, such a database probably
does not exist. The strength of administrative databases,
such as that of Medicare is that they allow the observation
of large numbers of patients for which practice patterns
can be evaluated as they occur in actual clinical practice.
Furthermore, administrative databases allow the observa-
tion of practice patterns outcomes associations in large
numbers of unselected patients.
However, the limitations of such databases include the
missing information about potential confounding factors,
such as severity of illness, and the limited ability to meas-
ure exposure and outcome accurately. Many databases
that are not designed for clinical research either mismeas-
ure patient outcomes or fail to capture outcomes that are
important to both physicians and patients (such as quali-
ty of life and functional status). The control of these biases
was the basis of the methodological framework for out-
comes research proposed in this chapter.
The application of outcomes research methods to practice 
guideline evaluation
The application of outcomes research methods to practice
guideline evaluation can accomplish several goals. One
important goal is the evaluation of practice guidelines,
that is, to determine to what extent the guidelines accom-
plished their primary goals after their dissemination. We
have suggested the model of chronic disease epidemiolo-
gy as the methodological framework for outcomes re-
search to evaluate practice guidelines.
The steps to evaluate practice guidelines using outcomes
research when the basic design is a retrospective cohort
study are summarized in Figure 3 Some limitations to the
application of this model exist. The reasons for the inabil-
ity of the proposed methodological framework to deal
completely with the intrinsic biases in outcomes research
are listed in Figure 4. They relate mostly to the databases
usually used in studies of outcomes research.
Summary
The proposed methodological framework for outcomes
research to evaluate practice guidelines reflects the selec-
tion, information and confounding biases inherent in its
observational nature which must be accounted for in both
the design and the analysis phases of any outcomes re-
search study. Indeed, a major limitation of outcomes re-
search is the inability to account for unobserved
heterogeneity that directly correlates with practice pat-
terns and/or health outcomes. This may lend bias to any
inferences made about practice variations and outcomes.
"Researchers cannot correct for the subtle reason doctors
choose one treatment over another for a particular pa-
tient. That bias, in turn, can undermine the entire premise
of outcomes research" [110]. These are intrinsic properties
of outcomes research that can be dealt with only in part,
by applying the principles of chronic disease epidemiolo-
gy. Thus, this proposed methodology can serve as a frame-
work for the conduct of outcomes research in the
evaluation of practice guidelines but its application will
be limited.
Figure 3
Steps to evaluate practice guidelines using outcomes
research
1.  Can a large database be identified that contains information on practice patterns 
for the treatment of a condition for which practice guidelines have been 
developed? 
 
2.  Is the database suitable for guideline evaluation in terms of the following criteria? 
 
   a.  Can a precise diagnosis be made using the available data? 
  
    b.  Can criteria be established to allow for the creation of comparison groups with 
different practice patterns? 
c.  Are there data to ensure the comparability of the groups? 
 
d.  Can practice patterns be measured? 
 
e.  Can practice patterns be identified according to those prescribed by practice 
guidelines? 
 
f.  Are there any data on patient, physician, and environmental factors that could 
explain deviations from practice prescribed by practice guidelines and that could 
help validate any inference made about practice patterns–outcomes associations? 
 
g.  Are outcomes of interest related to the purpose of clinical guidelines to enhance 
the quality, appropriateness, and effectiveness of health care, available and 
measured with precision? 
 
h.  Are the incidence rates or prevalence of the outcomes of interest large enough to 
allow meaningful practice patterns–outcomes associations? 
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